Challenges and Reforms in Medicare Advantage's Prior Authorization Process

Margaret Hvatum, a 70-year-old part-time computer science professor, depends on the medication Hizentra to manage her primary immunodeficiency. Without insurance, this home-administered drug costs $8,141.94 for a 28-day supply. Her Medicare Advantage plan through Humana initially denied coverage for Hizentra, highlighting challenges within the prior authorization process in health insurance.

The prior authorization process requires insurance company approval before certain treatments or medications are administered. When Hvatum transitioned to a new Medicare Advantage plan, her request for Hizentra was denied because her prior authorization did not transfer. This led to missed doses, resulting in a hospitalization due to a urinary tract infection.

In 2024, Medicare Advantage plans processed nearly 53 million prior authorization requests, with numerous denials affecting patient care. Carrie Graham, director of the Medicare Policy Initiative at Georgetown University, assesses insurers' financial motivations, noting the profit when care costs less than the payments received.

Efforts to Improve Prior Authorization Efficiency

Recent initiatives aim to lessen the burden of prior authorizations. Several insurers, including Humana, are committed to streamlining these processes, though changes often exclude prescription medications. Humana has partially responded by reducing prior authorization mandates for outpatient services, enhancing efficiency for patients and providers.

Hvatum's experience mirrors the struggles many face with prior authorizations. Her appeals against insurance denials for both her medication and related hospitalizations were eventually successful, but the system remains time-consuming and frustrating for patients.

Although Humana reversed its initial decision, granting her medication access until year-end, Hvatum and her husband consider moving to Norway for potentially more stable healthcare options. Her case underscores the critical need for reform in prior authorization processes to balance patient care with cost management, highlighting an ongoing challenge within the insurance industry.